Jushi Holdings (JUSHF) Enterprise Value (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Enterprise Value of -$33.3 million for Q2 2026, down 45.5% year-over-year from -$61.2 million in Q2 2025, and up 16.05% quarter-over-quarter from -$39.7 million in Q1 2026.
Jushi Holdings (JUSHF) Enterprise Value (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Enterprise Value for 6 consecutive years, with -$33.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Enterprise Value fell 45.5% year-over-year to -$33.3 million; the TTM figure through Jun 2026 stood at -$33.3 million (down 45.5% YoY), while the FY2025 annual figure was -$24.0 million, down 23.19% from the prior year.
- Enterprise Value climbed to -$33.3 million in Q2 2026 per JUSHF's latest filing, from -$39.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$19.5 million in Q4 2024 and bottomed at -$44.6 million in Q2 2022.
- Historically, Enterprise Value has averaged -$28.7 million across 5 years, with a median of -$29.7 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 71.37% — and 2026, when it tumbled 54.71%.
- Jushi Holdings' Enterprise Value stood at -$27.6 million in 2022, then fell by 10.73% to -$30.5 million in 2023, then surged by 36.08% to -$19.5 million in 2024, then retreated by 23.19% to -$24.0 million in 2025, then tumbled by 38.6% to -$33.3 million in 2026.
- Business Quant data shows JUSHF's Enterprise Value at -$33.3 million in Q2 2026, -$39.7 million in Q1 2026, and -$24.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.38 Bn | 43.42 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.66 Bn | 40.00 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 32.33 Bn | 30.66 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.04 Bn | 19.37 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -33.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.33 Mn |
| Mar 31, 2026 | -39.70 Mn |
| Dec 31, 2025 | -24.05 Mn |
| Sep 30, 2025 | -23.17 Mn |
| Jun 30, 2025 | -22.91 Mn |
| Mar 31, 2025 | -25.66 Mn |
| Dec 31, 2024 | -19.52 Mn |
| Sep 30, 2024 | -20.74 Mn |
| Jun 30, 2024 | -32.88 Mn |
| Mar 31, 2024 | -29.80 Mn |
| Dec 31, 2023 | -30.54 Mn |
| Sep 30, 2023 | -29.71 Mn |
| Jun 30, 2023 | -31.30 Mn |
| Mar 31, 2023 | -19.86 Mn |
| Dec 31, 2022 | -27.58 Mn |
| Sep 30, 2022 | -32.45 Mn |
| Jun 30, 2022 | -44.57 Mn |
| Dec 31, 2021 | -96.35 Mn |